Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains
- 12 January 2023
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 61 (3) , 106715
Abstract
No abstract availableKeywords
Funding Information
- Mazandaran University of Medical Sciences (11511)
This publication has 17 references indexed in Scilit:
- High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?Journal of Medical Microbiology, 2016
- In Vitro Combination of Voriconazole and Miltefosine against Clinically Relevant MoldsAntimicrobial Agents and Chemotherapy, 2014
- Treatment Options in Invasive AspergillosisCurrent Treatment Options in Infectious Diseases, 2014
- In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogensJournal of Antimicrobial Chemotherapy, 2013
- Synthesis and antifungal activities of miltefosine analogsBioorganic & Medicinal Chemistry Letters, 2013
- Limited Activity of Miltefosine in Murine Models of Cryptococcal Meningoencephalitis and Disseminated CryptococcosisAntimicrobial Agents and Chemotherapy, 2013
- Clinical Implications of Azole Resistance inAspergillus fumigatus, the Netherlands, 2007–2009Emerging Infectious Diseases, 2011
- Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New WorldActa Tropica, 2011
- Pharmacokinetics of Miltefosine in Old World Cutaneous Leishmaniasis PatientsAntimicrobial Agents and Chemotherapy, 2008
- Hexadecylphosphocholine (Miltefosine) Has Broad-Spectrum Fungicidal Activity and Is Efficacious in a Mouse Model of CryptococcosisAntimicrobial Agents and Chemotherapy, 2006